Estudio prospectivo comparativo de dos métodos de cálculo individual de la actividad de 131I en el tratamiento del hipertiroidismo

Silberstein, 2012, Radioiodine: The classic theranostic agent, Semin Nucl Med., 42, 164, 10.1053/j.semnuclmed.2011.12.002 Lee, 2012, Radioactive iodine therapy, Curr Opin Endocrinol Diabetes Obes., 19, 420, 10.1097/MED.0b013e328357fa0c Hertz, 1946, Radioactive iodine in the study of thyroid physiology; The use of radioactive iodine therapy in hyperthyroidism, JAMA, 131, 81, 10.1001/jama.1946.02870190005002 Seldin, 1946, Effect on functioning metastases of adenocarcinoma of thyroid, JAMA, 132, 837 Ross, 2016, 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis, Thyroid., 26, 1343, 10.1089/thy.2016.0229 DeGroot, 2000, Graves’ disease and the manifestations of thyrotoxicosis 2007 2015, Insights Imaging., 6, 411, 10.1007/s13244-015-0410-4 Stokkel, 2010, EANM procedure guidelines for therapy of benign thyroid disease, Eur J Nucl Med Mol Imaging., 37, 2218, 10.1007/s00259-010-1536-8 Brunn, 1981, Volumetric analysis of thyroid lobes by real-time ultrasound (author's transl.), Dtsch Med Wochenschr., 106, 1338, 10.1055/s-2008-1070506 Gotthardt, 2006, What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?, Nuklearmedizin., 45, 206, 10.1055/s-0038-1625221 Marinelli, 1948, Dosage determination with radioactive isotopes; practical considerations in therapy and protection, Am J Roentgenol Radium Ther., 59, 260 Schlafke-Stelson, 1995, A history of medical internal dosimetry, Health Phys., 69, 766, 10.1097/00004032-199511000-00011 Pena Pardo, 2012, Estudio prospectivo comparativo de 2 métodos de cálculo individual de la actividad de 131I en el tratamiento del hipertiroidismo: resultados preliminares, Rev Esp Med Nucl Imagen Mol, 31, 37 Bonnema, 2012, Radioiodine therapy in benign thyroid diseases: Effects, side effects, and factors affecting therapeutic outcome, Endocr Rev., 33, 920, 10.1210/er.2012-1030 Bernard, 2014, Radioiodine therapy in benign thyroid disorders. Evaluation of French nuclear medicine practices, Ann Endocrinol (Paris)., 75, 241, 10.1016/j.ando.2014.07.863 Shapiro, 1993, Optimization of radioiodine therapy of thyrotoxicosis: What have we learned after 50 years?, J Nucl Med., 34, 1638 Weetman, 2007, Radioiodine treatment for benign thyroid diseases, Clin Endocrinol (Oxf)., 66, 757, 10.1111/j.1365-2265.2007.02841.x Van Isselt, 2007, Radioiodine treatment of hyperthyroidism: Fixed or calculated doses; intelligent design or science?, Eur J Nucl Med Mol Imaging., 34, 883, 10.1007/s00259-007-0592-1 Sisson, 2007, Radioiodine treatment of hyperthyroidism: Fixed or calculated doses; intelligent design or science?, Eur J Nucl Med Mol Imaging., 34, 1129, 10.1007/s00259-007-0419-0 Leow, 2009, Iodine-131 therapy for hyperthyroidism prescribed by endocrinologist — our preliminary experience, Exp Clin Endocrinol Diabetes., 117, 616, 10.1055/s-0028-1102919 Jönsson, 2004, Excess radiation absorbed doses from non-optimised radioiodine treatment of hyperthyroidism, Radiat Prot Dosimetry., 108, 107, 10.1093/rpd/nch013 De Rooij, 2009, Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: Systematic review and meta-analysis, Eur J Endocrinol., 161, 771, 10.1530/EJE-09-0286 Rokni, 2014, Efficacy of different protocols of radioiodine therapy for treatment of toxic nodular goiter: Systematic review and meta-analysis of the literature, Int J Endocrinol Metab., 12, e14424, 10.5812/ijem.14424 Dunkelmann, 2005, Results of a risk adapted and functional radioiodine therapy in Graves’ disease, Nuklearmedizin., 44, 238, 10.1055/s-0038-1625320 Kobe, 2008, Graves’ disease and radioiodine therapy: Is success of ablation dependent on the achieved dose above 200Gy?, Nuklearmedizin., 47, 13, 10.3413/nukmed-0087 Metso, 2004, Long-term follow-up study of radioiodine treatment of hyperthyroidism, Clin Endocrinol (Oxf)., 61, 641, 10.1111/j.1365-2265.2004.02152.x Szumowski, 2015, Radioiodine therapy for Graves’ disease — retrospective analysis of efficacy factors, Endokrynol Pol., 66, 126, 10.5603/EP.2015.0019 Kaise, 1991, Thyrotropin receptor antibody activities significantly correlate with the outcome of radioiodine (131I) therapy for hyperthyroid Graves’ disease, Endocrinol Jpn., 38, 429, 10.1507/endocrj1954.38.429 Gessl, 2012, Thyroid disorders, Handb Exp Pharmacol., 361